- Darling Ingredients Inc's DAR health brand Rousselot launches Quali-Pure, a range of gelatins for biomedical applications with controlled endotoxin levels.
- Quali-Pure was specifically designed for various applications, including embolization, wound healing, drug delivery, vaccines, and hemostatics.
- Quali-Pure is the latest addition to the Rousselot Biomedical portfolio that consists of X-Pure biomedical gelatins, hydrolyzed gelatins, and modified gelatins.
- Quali-Pure gelatins are available from October 2021, with Quali-Pure hydrolyzed gelatins to be added to the portfolio shortly.
- Price Action: DAR shares are trading higher by 2.51% at $77.56 on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
